Global Brachytherapy Therapy Market 2018-2024

Global Brachytherapy Devices Market – Drivers, Opportunities, Trends, and Forecasts: 2018–2024
Overview:
Brachytherapy is a medical procedure popularly referred to as radiation therapy. It is used to treat various types of cancers which involves placing radioactive materials inside the body, which is called internal radiation. Surgeons deliver high dose of radiation to the target site. There are fewer side effects and complications involved in this procedure than surgery and external beam radiation. Brachytherapy is administered with high precision, in high doses, and is localized. Brachytherapy procedure is as follows:
A thin catheter is placed at the target site or in the tumor and is connected to a high-dose rate (HDR) afterload. The system consists of a single highly radioactive indium pellet at the tip of the wire. The pellet is pushed into the catheter one by one (performed under computer control). This is called dwell time. The pellet is stopped near the target site to release radiation at the dwell position. Brachytherapy offers precise treatment for few minutes and after a series of treatment, the catheters are removed from the target site and the individual may finally have no radioactive seeds left inside the body.
Brachytherapy is considered the best way of eliminating or destroying cancerous tissues. This treatment has the potential to kill cancer cells and shrink tumors. It involves no external X-ray beams and surgery and has minimal invasiveness. Internal beam radiation therapy allows a higher dose of radiation in a smaller target area. This may not be possible with external beam radiation therapy. It uses a radiation dose source that is usually sealed in a small holder known as an implant. Brachytherapy helps to identify and position the device appropriately to aim at the target site providing an effective treatment for tumor. It takes lesser time than other procedures. The special preparations required before initiating Brachytherapy are: Bowel preparation, blood test, pre-treatment (ultrasound, CT or MRI scan)
The Brachytherapy device market is progressing at a steady pace and is expected to grow at a rapid rate in the emerging economies. According to the estimation of the National Cancer Institute, in the US around 1.6 million new cases of cancer were diagnosed, and 595,690 people died due to cancer in 2016. Cancer is one of the biggest causes of mortality and morbidity in Europe after cardiovascular diseases. The highest cancer rate for men and women together was found in Denmark with 338 people per 100,000, the highest for any EU country. According to ICMR, India is likely to have over 17.3 lakh new cases of cancer and over 8.8 lakh deaths due to the disease by 2020 with breast, lung, and cervical cancers topping the list.
The main products in the Brachytherapy market include:
• Oncentra Brachy Treatment Planning System by Elekta
• Brachytherapy Afterloaders and Applicators by Varian Medical Systems
• SOURCELINK Delivery System by C.R. Bard (now BD)
• FASTFILL Brachytherapy Needle by C.R. Bard (now BD)
• IsoSeed, IsoStrand, and LDR Needles by Eckert & Ziegler BEBIG
• TheraStrand – Strand and AnchorLoad – needle by Theragenics
Market Analysis:
The Global Brachytherapy Device Market is estimated to witness a CAGR of 6.06% during the forecast period 2018–2024. The market is analyzed based on three segments, namely product type, end-users, and regions.
Regional Analysis:
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is set to be the leading region for the brachytherapy devices growth followed by the Europe. Asia Pacific and ROW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in the patient population and their focus toward healthcare infrastructure. The brachytherapy devices market has the lowest penetration in the emerging market and most of the vendors are targeting to penetrate countries such as India, China, Thailand, and Vietnam.
APAC is the most focused and has substantial growth due to vast opportunities for vendors to establish their presence. Factors such as growing public awareness, increase in aging population, growing assisted living facilities, presence of large potential customer base, and increased initiatives by government support will boost the market growth. The region is witnessing a rapid growth in the healthcare industry as well. The emerging countries such as India and China are majorly focusing to improve their healthcare infrastructure and the governments have taken initiatives to develop the healthcare facilities in both urban and rural areas. The increased demand for better services among patients and the increased life expectancy in this region are factors that will boost the overall healthcare facility in the region. Also, countries in this region have a strong focus towards the development of healthcare that will include coverage for patients aged 65 and above.
Product Analysis:
Brachytherapy devices market is expected to increase rapidly. HDR segment has the maximum share in the global brachytherapy devices market. Developments in imaging technology coupled with advancements in computer technology, have revolutionized the processes for tumor targeting and radiation therapy planning. Technologies used in internal beam radiation therapy include high dose rate (HDR) brachytherapy, low dose rate (LDR) brachytherapy, intermediate dose rate, and pulsed dose rate; and products include seeds, applicators, after loaders, and accessories. Based on applications, the market is segmented into prostate cancer, cervical cancer, gallbladder, uterus, breast cancer, lung cancer, head & neck cancer, brain cancer, and others. Based on end-users, the market is segmented into hospitals, radiation therapy centers, ambulatory service centers, and others.
Key Players:
Elekta AB, Varian Medical Systems, C.R. Bard (now Becton, Dickinson and Company), Eckert & Ziegler BEBIG SA, and Theragenics are the predominant players in the current brachytherapy devices market.
Competitive Analysis:
The global brachytherapy devices market is highly fragmented and has immense growth opportunities for vendors, especially in the developing regions. The market enjoys the participation of many global, regional, and local players who are competing fiercely to gain a strong foothold as top vendor. Big players, such Elekta AB, Varian Medical Systems, and C.R. Bard (now BD) often acquire small yet promising companies to increase their market share. Most giant companies are using acquisition strategies to expand their business operations by leveraging their products portfolio across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&A. Strategic alliances are being formed to manufacture and market brachytherapy devices more vigorously and efficiently
Benefits:
The report provides complete details about the usage and adoption rate of brachytherapy devices for the treatment of various cancer. Thus, the key stakeholders can find out all the relevant details about the latest trends, drivers, investments, vertical players’ initiatives, and government initiatives toward the radiation industry in the upcoming years. The report also provides details of the pure play companies entering the market. Moreover, the report highlights the major challenges that are going to impact the market growth. Additionally, it brings forth the key business opportunities to prominent stakeholders to aid them in expanding their businesses and capture the revenue in specific verticals. It also aims to help stakeholders analyze the pros and cons of this market before investing or expanding the business in this arena.
Key Stakeholders:

Table of Contents
1 Industry Outlook 10
1.1 Industry Overview 10
1.2 Patient demographics 12
1.3 Healthcare Spending in the US 14
1.4 Definition: Brachytherapy 15
1.5 Why brachytherapy? 15
1.6 Industry Trends 15
1.7 Emerging Global Markets 16
2 Report Outline 18
2.1 Report Scope 18
2.2 Report Summary 18
2.3 Research Methodology 19
2.4 Report Assumptions 20
3 Market Snapshot 21
3.1 Total Addressable Market (TAM) 21
3.2 Funding Scenario 22
3.3 Segmented Addressable Market (SAM) 22
3.4 Porter 5 (Five) Forces 25
3.5 Market Dynamics 26
3.5.1 Drivers 27
3.5.1.1 Rise in the incidence of cancer globally 27
3.5.1.2 Increasing popularity of MI surgeries 27
3.5.1.3 Increase in the number of outpatient procedures 27
3.5.1.4 Rise in elderly population 28
3.5.2 Restraints 28
3.5.2.1 Complications and risks associated with brachytherapy procedures 28
3.5.2.2 High costs of instrument and therapy 28
3.5.2.3 Lack of trained technicians in developing countries 29
3.5.2.1 Intense competition among vendors 29
3.5.3 Opportunities 29
3.5.3.1 Advancement in technology 29
3.5.3.2 Increasing adoption of non-invasive procedures in emerging countries 30
3.5.3.1 Increasing healthcare spending 30
3.5.3.1 Shift toward minimal and non-invasive procedures 31
3.5.4 DRO – Impact Analysis 32
3.5.5 Key Stakeholders 33
4 Brachytherapy Market Segmentation by Methods: Market Size & Analysis 34
4.1 Overview 34
4.2 High-dose Rate Brachytherapy Market 37
4.2.1 Overview 37
4.3 Low-dose Rate Brachytherapy Market 37
4.3.1 Overview 37
4.4 Intermediate Dose Rate Brachytherapy Market 38
4.4.1 Overview 38
4.5 Pulsed Dose Rate Brachytherapy Market 39
4.5.1 Overview 39
5 Brachytherapy Market Segmentation By consumables 40
5.1 Overview 40
5.2 Seeds 40
5.3 Applicators, Afterloaders, and Other Accessories 41
6 Brachytherapy Market Segmentation by Applications 43
6.1 Overview 43
6.2 Prostate Cancer 43
6.3 Cervical Cancer 44
6.4 Breast Cancer 44
6.5 Lung Cancer 45
6.6 Head & Neck Cancer 46
6.7 Brain Cancer 47
6.8 Others 47
7 End-users: Market Size and Analysis 48
7.1 Overview 48
7.2 Hospitals 48
7.3 Radiation Therapy Centers 49
7.4 Ambulatory Surgery Centers 49
7.5 Others 49
8 Regions: Market Size & Analysis 51
8.1 Overview 51
8.2 North America 52
8.2.1 Market Overview 52
8.2.2 US 53
8.2.3 Canada 54
8.3 Europe 54
8.3.1 Market Overview 54
8.3.2 UK 55
8.3.3 Germany 55
8.3.4 France 56
8.3.5 Spain 56
8.4 APAC 56
8.4.1 Market Overview 56
8.4.2 India 57
8.4.3 China 58
8.4.4 Japan 59
8.5 Rest of the World 59
8.5.1 Market Overview 59
8.5.2 Brazil 60
8.5.3 Middle East 60
9 Competitive Landscape 62
9.1 Competitor Comparison Analysis 62
10 Vendor Profiles 64
10.1 Elekta AB 64
10.1.1 Overview 64
10.1.2 Geographic Revenue 68
10.1.3 Business Focus 68
10.1.4 SWOT Analysis 69
10.1.5 Business Strategies 69
10.2 Varian Medical Systems Inc. 70
10.2.1 Overview 70
10.2.2 Business Units 74
10.2.3 Geographic Revenue 75
10.2.4 Business Focus 75
10.2.5 SWOT Analysis 76
10.2.6 Business Strategies 76
10.3 C. R. Bard Inc. 78
10.3.1 Overview 78
10.3.2 Business Units 80
10.3.3 Business Focus 81
10.3.4 SWOT Analysis 81
10.3.5 Business Strategies 81
10.4 Eckert & Ziegler BEBIG 83
10.4.1.1 Overview 83
10.4.1.2 Business Units 85
10.4.1.3 Business Units 85
10.4.1.4 Geography 86
10.4.1.5 Business Focus 86
10.4.1.6 SWOT Analysis 87
10.4.1.7 Business Strategies 87
10.5 Theragenics Corp 88
10.5.1.1 Overview 88
10.5.1.2 Business Units 89
10.5.1.3 Business Focus 89
10.5.1.4 SWOT Analysis 89
10.5.1.5 Business Strategies 90
11 Companies to watch for 90
11.1 Carl Zeiss Meditec AG 91
11.1.1 Overview 91
11.2 Mevion Medical Systems Inc. 92
11.2.1 Overview 92
11.3 Nordion Inc. 93
11.3.1 Overview 93
11.4 IsoRay Inc. 95
11.4.1 Overview 95
11.5 Hitachi Medical Corp. 96
11.5.1 Overview 96
11.6 ViewRay Inc. 98
11.6.1 Overview 98

List of Tables

TABLE 1 FUNDING SCENARIO 22
TABLE 2 GLOBAL BRACHYTHERAPY DEVICES MARKET BY TYPES, 2017–2024 ($MILLION) 36
TABLE 3 GLOBAL BRACHYTHERAPY DEVICES MARKET REVENUE BY REGIONS FORECAST, 2017–2024 ($MILLION) 52
TABLE 1 GLOBAL BRACHYTHERAPY DEVICES MARKET BY VENDOR RANKING, 2017 63
TABLE 2 ELEKTA AB: PRODUCT OFFERINGS 64
TABLE 3 ELEKTA AB: RECENT DEVELOPMENTS 66
TABLE 4 VARIAN MEDICAL SYSTEMS INC.: PRODUCT OFFERINGS 70
TABLE 5 VARIAN MEDICAL SYSTEMS INC.: RECENT DEVELOPMENTS 72
TABLE 6 C. R. BARD INC.: PRODUCT OFFERINGS 78
TABLE 7 C. R. BARD INC.: RECENT DEVELOPMENTS 79
TABLE 8 ECKERT & ZIEGLER BEBIG: PRODUCT OFFERINGS 83
TABLE 9 ECKERT & ZIEGLER BEBIG: RECENT DEVELOPMENTS 83
TABLE 10 THERAGENICS CORP: PRODUCT OFFERINGS 88
TABLE 11 THERAGENICS CORP: RECENT DEVELOPMENTS 88
TABLE 12 CARL ZEISS MEDITEC AG: SNAPSHOT 91
TABLE 13 CARL ZEISS MEDITEC AG: RECENT DEVELOPMENTS 91
TABLE 14 MEVION MEDICAL SYSTEMS INC.: SNAPSHOT 92
TABLE 15 MEVION MEDICAL SYSTEMS INC.: RECENT DEVELOPMENTS 92
TABLE 16 NORDION INC.: SNAPSHOT 93
TABLE 17 NORDION INC.: RECENT DEVELOPMENTS 93
TABLE 18 ISORAY INC.: SNAPSHOT 95
TABLE 19 ISORAY INC.: RECENT DEVELOPMENTS 95
TABLE 20 HITACHI MEDICAL CORP.: SNAPSHOT 96
TABLE 21 HITACHI MEDICAL CORP.: RECENT DEVELOPMENTS 96
TABLE 22 VIEWRAY INC.: SNAPSHOT 98
TABLE 23 VIEWRAY INC.: RECENT DEVELOPMENTS 98

List of Charts

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 11
CHART 2 AGEING DEMOGRAPHIC GROWTH 13
CHART 3 US POPULATION DISTRIBUTION BY AGE (US, CENSUS BUREAU, CMS 2015) 13
CHART 4 US HEALTHCARE CONSUMPTION BY AGE (US, CENSUS BUREAU, CMS 2015) 14
CHART 5 WORLD POPULATION AGED 65 YEARS AND ABOVE, 1960-2060 (%) 14
CHART 6 GLOBAL HEALTHCARE EXPENDITURE GDP AND PER-CAPITA SPENDING IN 2015 16
CHART 8 RESEARCH METHODOLOGY 19
CHART 9 GLOBAL RADIATION ONCOLOGY MARKET BY THERAPY TYPE, 2017 (%) 22
CHART 10 GLOBAL BRACHYTHERAPY DEVICES MARKET REVENUE, 2017-2024 ($MILLION) 23
CHART 11 PORTERS 5 FORCES ON BRACHYTHERAPY DEVICES MARKET 25
CHART 12 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES 26
CHART 13 DRO - IMPACT ANALYSIS OF BRACHYTHERAPY DEVICES MARKET 32
CHART 14 KEY STAKEHOLDERS 33
CHART 15 GLOBAL BRACHYTHERAPY DEVICES MARKET BY TYPE SEGMENTATION, 2017 (% SHARE) 34
CHART 16 GLOBAL BRACHYTHERAPY DEVICES MARKET BY TYPE SEGMENTATION, 2024 (% SHARE) 35
CHART 17 GLOBAL BRACHYTHERAPY DEVICES MARKET OVERVIEW BY PRODUCT TYPE 2017 35
CHART 18 GLOBAL HIGH-DOSE RATE BRACHYTHERAPY MARKET BY REVENUE, 2017–2024 ($MILLION) 37
CHART 19 GLOBAL LOW DOSE RATE BRACHYTHERAPY MARKET BY REVENUE, 2017–2024 ($MILLION) 38
CHART 20 GLOBAL INTERMEDIATE DOSE RATE MARKET BY REVENUE, 2017–2024 ($MILLION) 38
CHART 21 GLOBAL PULSED DOSE RATE MARKET BY REVENUE, 2017–2024 ($MILLION) 39
CHART 22 GLOBAL BRACHYTHERAPY DEVICES MARKET SHARE BY CONSUMABLES SEGMENTATION, 2017 (%) 40
CHART 23 GLOBAL BRACHYTHERAPY DEVICES MARKET SEGMENTATION BY PRODUCT TYPE, 2017-2024 ($MILLION) 41
CHART 24 GLOBAL BRACHYTHERAPY DEVICES MARKET SEGMENTATION BY PRODUCT TYPE, 2016-2023 (% SHARE) 42
CHART 25 GLOBAL BRACHYTHERAPY MARKET SHARE BY APPLICATION SEGMENTATION, 2017 (%) 43
CHART 26 GLOBAL BRACHYTHERAPY MARKET SHARE BY END-USERS SEGMENTATION, 2017 (%) 48
CHART 27 GLOBAL BRACHYTHERAPY DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 51
CHART 28 GLOBAL BRACHYTHERAPY DEVICES MARKET OVERVIEW BY REGIONS 2017 ($ MILLION) 51
CHART 29 BRACHYTHERAPY DEVICES MARKET REVENUE IN NORTH AMERICA, 2017–2024 ($MILLION) 52
CHART 30 BRACHYTHERAPY DEVICES MARKET REVENUE IN THE EUROPE, 2017–2024 ($MILLION) 54
CHART 31 BRACHYTHERAPY DEVICES MARKET REVENUE IN THE APAC, 2017–2024 ($MILLION) 57
CHART 32 BRACHYTHERAPY DEVICES MARKET REVENUE IN THE REST OF THE WORLD, 2017–2024 ($MILLION) 59
CHART 33 GLOBAL BRACHYTHERAPY DEVICES MARKET SEGMENTATION BY GEOGRAPHY, 2017-2024 ($MILLION) 60
CHART 34 GLOBAL BRACHYTHERAPY DEVICES MARKET SEGMENTATION BY GEOGRAPHY, 2017-2024 (%) 61
CHART 35 ELEKTA AB: OVERVIEW SNAPSHOT 65
CHART 36 ELEKTA AB: GEOGRAPHIC REVENUE 68
CHART 37 ELEKTA AB: SWOT ANALYSIS 69
CHART 38 VARIAN MEDICAL SYSTEMS INC.: OVERVIEW SNAPSHOT 72
CHART 39 VARIAN MEDICAL SYSTEMS INC.: BUSINESS UNITS 74
CHART 40 VARIAN MEDICAL SYSTEMS INC.: GEOGRAPHIC REVENUE 75
CHART 41 VARIAN MEDICAL SYSTEMS INC.: SWOT ANALYSIS 76
CHART 42 C. R. BARD INC.: OVERVIEW SNAPSHOT 79
CHART 43 C. R. BARD INC.: BUSINESS UNITS 80
CHART 44 C. R. BARD INC.: SWOT ANALYSIS 81
CHART 45 ECKERT & ZIEGLER BEBIG: OVERVIEW SNAPSHOT 84
CHART 46 ECKERT & ZIEGLER BEBIG: BUSINESS UNITS 86
CHART 47 ECKERT & ZIEGLER BEBIG: GEOPGRAPHICAL PRESENCE 86
CHART 48 ECKERT & ZIEGLER BEBIG: SWOT ANALYSIS 87
CHART 49 THERAGENICS CORP: SWOT ANALYSIS 89